ASX - By Stock
|
PER |
Re:
Ann: WHO selects proposed INN for ATL1102
|
|
Fredrickdouglas
|
16 |
6.0K |
4 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
16
|
6.0K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Fredrickdouglas
|
892 |
220K |
13 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
892
|
220K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy
|
|
Fredrickdouglas
|
65 |
16K |
31 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
65
|
16K
|
31
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy
|
|
Fredrickdouglas
|
65 |
16K |
11 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
65
|
16K
|
11
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
5 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Annual Report
|
|
Fredrickdouglas
|
8 |
3.6K |
3 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
8
|
3.6K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Share Purchase Plan (SPP) Offer Booklet
|
|
Fredrickdouglas
|
86 |
23K |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
86
|
23K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
3 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Director's Interest Notice (CG,JG)
|
|
Fredrickdouglas
|
2 |
951 |
13 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
2
|
951
|
13
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
7 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
190
|
49K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Share Purchase Plan (SPP) Offer Booklet
|
|
Fredrickdouglas
|
86 |
23K |
1 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
86
|
23K
|
1
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
3 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
190
|
49K
|
3
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
190
|
49K
|
2
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
11 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
190
|
49K
|
11
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
24 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
190
|
49K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Other indications
|
|
Fredrickdouglas
|
64 |
16K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
PER |
James Garner AKA JG
|
|
Fredrickdouglas
|
190 |
49K |
11 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
190
|
49K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Share Purchase Plan (SPP) Offer Booklet
|
|
Fredrickdouglas
|
86 |
23K |
2 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
86
|
23K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive new DMD Combination Therapy Data in mdx mice
|
|
Fredrickdouglas
|
66 |
18K |
3 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
66
|
18K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
Fredrickdouglas
|
75 |
21K |
5 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
75
|
21K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities Report
|
|
Fredrickdouglas
|
5 |
1.3K |
3 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
5
|
1.3K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Institutional Placement and proposed Share Purchase Plan SPP
|
|
Fredrickdouglas
|
71 |
19K |
0 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
71
|
19K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Fredrickdouglas
|
158 |
44K |
0 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Fredrickdouglas
|
158 |
44K |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Fredrickdouglas
|
158 |
44K |
10 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Fredrickdouglas
|
158 |
44K |
3 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
9 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
8 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
5 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
|
|
Fredrickdouglas
|
29 |
8.4K |
12 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
29
|
8.4K
|
12
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
Fredrickdouglas
|
98 |
29K |
0 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
98
|
29K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
Fredrickdouglas
|
98 |
29K |
3 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
98
|
29K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
|
|
Fredrickdouglas
|
34 |
12K |
5 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
34
|
12K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
Fredrickdouglas
|
98 |
29K |
13 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
98
|
29K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Fredrickdouglas
|
99 |
28K |
6 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
99
|
28K
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Fredrickdouglas
|
1.0K |
304K |
9 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
1.0K
|
304K
|
9
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
4 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
2 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Fredrickdouglas
|
99 |
28K |
5 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
99
|
28K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
Fredrickdouglas
|
107 |
28K |
0 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
107
|
28K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
Fredrickdouglas
|
107 |
28K |
5 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
107
|
28K
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Fredrickdouglas
|
1.0K |
304K |
10 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
1.0K
|
304K
|
10
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Fredrickdouglas
|
1.0K |
304K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
1.0K
|
304K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Fredrickdouglas
|
1.0K |
304K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
1.0K
|
304K
|
1
|
|